Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Novelion Therapeutics (Visudyne)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

A medical technology in British Columbia, Canada. It is used to treat abnormal growth of leaky blood vessels in the eye caused by wet age-related macular degeneration.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Devices and Supplies
Primary Office
  • 1800 - 510 West Georgia Street
  • Vancouver, British Columbia V6B 0M3
  • Canada

Novelion Therapeutics (Visudyne) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Novelion Therapeutics (Visudyne)‘s full profile, request access.

Request full access to PitchBook

Novelion Therapeutics (Visudyne) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Novelion Therapeutics (Visudyne)‘s full profile, request access.

Request full access to PitchBook